期刊文献+

血清铁蛋白在强直性脊柱炎诊治中的价值 被引量:3

The value of serum ferritin in the diagnosis and treatment of ankylosing spondylitis
原文传递
导出
摘要 目的探究血清铁蛋白在强直性脊柱炎(AS)中诊治和监测病情活动度的价值。方法收集本院85例AS患者为疾病组,另外同期收集在本院体检的82例健康者为对照组,依据Bath强直性脊柱炎病情活动指标(BASDAI)分为缓解期和活动期期,检测所有入选人员的血清铁蛋白(SFe)、人类白细胞抗原(HLA)-B27(HLA-B27)、C-反应蛋白(CRP)和红细胞沉降率(ESR)水平,并统计分析。结果 AS组患者血清铁蛋白水平显著高于对照组(P <0. 05),活动期的血清铁蛋白显著高于缓解期(P <0. 05)。血清铁蛋白的灵敏度和特异度分别为82. 1%和73. 4%,SFe与BASDAI、CRP和ESR均呈正相关(r值分别为0. 84、0. 76、0. 68,P <0. 05)。结论血清铁蛋白不但是AS诊断指标之一,而且也是监测AS患者疾病活动的重要指标。 Objective To investigate the value of serum ferritin in the diagnosis of ankylosing spondylitis( AS) and that of evaluating the disease activity. Methods Eighty five cases of hospitalized RS( they were divided into the treatment group activity and mitigation period to BASDAI) were collected;the other group were 82 cases of healthy controls. The levels of serum ferritin( SFe),C-reactive protein( CRP),erythrocyte sedimentation rate( ESR) and human leukocyte antigen B27( HLA-B27) were tested for statistical analysis. Results The serum SFe level of AS group was significantly higher than the control group( P < 0. 05). In active RS group,the level of SFe was higher than mitigation RS group( P < 0. 05). The sensitivity and specificity of SFe were 82. 1% and 73. 4%,respectively,and SFe was positively correlated with BASDAI,CRP and ESR( r =0. 84,r = 0. 76,r = 0. 68,P < 0. 05). Conclusion SFe can be used not only as one of the RS for its diagnosis,but also as an important index in assessing the disease activity.
作者 黄荣 胡启擂 李宏 吕银江 HUANG Rong;HU Qi-lei;LI Hong;LV Yin-jiang(The First People's Hospital of Yuhang District,Hangzhou,Zhejiang 311000,China)
出处 《中国卫生检验杂志》 CAS 2020年第11期1370-1372,共3页 Chinese Journal of Health Laboratory Technology
关键词 强直性脊柱炎 血清铁蛋白 C-反应蛋白 红细胞沉降率 Ankylosing spondylitis Serum ferritin C-reactive protein Erythro-cyte sedimentation rate
  • 相关文献

参考文献10

二级参考文献74

  • 1Van der Linden S, vander Heijde D. Ankylosing spondylitis.// Ruddy S. Harris JR, Sledge CB. Kelley' s textbook of rheumatology. 6th ed. Philadelphia: W.B. Saunders Company, 2001 : 1039-1054.
  • 2vsn der Linden S, Valkeuburg HA, Cats A. Evaluation of dingnostic criteria for ankylosing spondylitis. A pmposal for medification Of the New York criteria. Arthritis Rheum, 1984,27:361-368.
  • 3Himyama M, Kohgo Y, Kondo H, et al. Regulation of iron metabolism in HepG2 Cell; a possible role for cytokines in the hepatic deposition of iron. Hepatology, 1993,18 : 874 -880.
  • 4Kobune M, Kohgo Y, Kato J, et al. Interleukin-6 enhance hepatictrans-ferring uptake expression in rats. Hepatology, 1994, 19: 1468-1475.
  • 5Braun J,Sieper J. Ankylosing spondylitis[J]. Lancet, 2007,369(9570):1379-1390.
  • 6Lukas C,Landewe R, Sieper J, et al. Development of an ASAS- endorsed disease activity score(ASDAS)in patients with ankylosing spondylitis[J]. Ann Rheum Dis,2009,68(1):18-24.
  • 7van der Heijde D,Lie E,Kvien TK, et al. ASDAS,a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis[J]. Ann Rheum Dis,2009, 68(12):1811-1818.
  • 8Machado P,Landewe R. Spondyloarthritis: Is it time to replace BASDAI with ASDAS?[J]. Nat Rev Rheumatol, 2013, 9(7):388-390.
  • 9Au YL,Wong WS, Mok MY, et al. Disease activity assessment in ankylosing spondylitis in a Chinese cohort : BASDAI or ASDAS?[J]. Clin Rheumatol, 2014,33(8):1127-1134.
  • 10Kilic E,Kilic G, Akgul O,et al. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score(ASDAS)in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study[J]. Rheumatol Int, 2015,35(6):981-989.

共引文献905

同被引文献32

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部